//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. 🌐 JAMADermatology.com
JAMA Dermatology









Loading...
Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4w0Jfaz
4h
Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4e9TYJH
Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4v43xjl
Pediatric patients waited 68% longer for appointments with pediatric dermatologists than with general dermatologists, and >30% of general dermatologists did not accept new pediatric patients. ja.ma/442Y7ZJ
Among adults with refractory #HidradenitisSuppurativa, golimumab led to durable improvement in disease severity; most responders used doses of 200–300 mg every 3–4 weeks. ja.ma/4ehcBKq
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/43YQbIX
An adolescent boy presented with more than 10-year history of skin discoloration and difficulty protruding the tongue. What is your diagnosis? Take the JAMA Dermatology Clinical Challenge: ja.ma/4e1kOn3
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3QBvakB
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3PWjUPE
#HidradenitisSuppurativa is associated with increased risks of self-harm and suicide, highlighting the importance of clinician vigilance and multidisciplinary mental health support. ja.ma/4ehM1Rt
2d
4d
5d
6d
3d
5d
1d
5d
6d
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology